We are live on ! Find out more
CBT

Central Bank & Trust Portfolio holdings

AUM $705M
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
-12.55%
1 Year Est. Return
+34.21%
3 Year Est. Return
+110%
5 Year Est. Return
+142.3%
10 Year Est. Return
+478.86%
AUM
$396M
AUM Growth
-$36M
Cap. Flow
+$28.1M
Cap. Flow %
7.09%
Top 10 Hldgs %
34.72%
Holding
283
New
19
Increased
49
Reduced
102
Closed
16

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$4.47M
2
MAS icon
Masco
MAS
+$4.05M
3
AET
Aetna Inc
AET
+$2.43M
4
AMAT icon
Applied Materials
AMAT
+$1.54M
5
MU icon
Micron Technology
MU
+$1.43M

Sector Composition

Rank Sector Weight
1 Technology 10.86%
2 Healthcare 10.86%
3 Financials 10.43%
4 Consumer Discretionary 7%
5 Consumer Staples 6.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
26
NextEra Energy
NEE
$185B
$4.82M 1.22%
110,980
+3,724
+3% +$163K
SYY icon
27
Sysco
SYY
$40.2B
$4.62M 1.16%
73,690
+1,328
+2% +$89.5K
EL icon
28
Estee Lauder
EL
$30.1B
$4.59M 1.16%
35,249
-2,816
-7% -$383K
VLO icon
29
Valero Energy
VLO
$90.5B
$4.37M 1.1%
58,300
-736
-1% -$64.7K
HPQ icon
30
HP
HPQ
$24.3B
$4.2M 1.06%
+205,144
New +$4.79M
XEL icon
31
Xcel Energy
XEL
$50.4B
$4.06M 1.03%
82,477
+223
+0.3% +$11.2K
REGN icon
32
Regeneron Pharmaceuticals
REGN
$69.9B
$3.87M 0.98%
+10,370
New +$3.8M
CELG
33
DELISTED
Celgene Corp
CELG
$3.85M 0.97%
60,015
-629
-1% -$46.4K
STZ icon
34
Constellation Brands
STZ
$22.2B
$3.59M 0.91%
22,328
+367
+2% +$72.9K
TROW icon
35
T. Rowe Price
TROW
$25.5B
$3.55M 0.9%
38,501
-7,726
-17% -$750K
PSX icon
36
Phillips 66
PSX
$83.3B
$3.36M 0.85%
39,054
-1,498
-4% -$146K
HUM icon
37
Humana
HUM
$45.8B
$3.31M 0.83%
11,548
-1,196
-9% -$379K
UNP icon
38
Union Pacific
UNP
$178B
$3.2M 0.81%
23,170
+14,877
+179% +$2.2M
SCZ icon
39
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$3.15M 0.8%
60,867
-11,538
-16% -$646K
EOG icon
40
EOG Resources
EOG
$74.7B
$3.12M 0.79%
35,807
-509
-1% -$54.5K
SBUX icon
41
Starbucks
SBUX
$118B
$3.06M 0.77%
47,478
-1,726
-4% -$108K
PGR icon
42
Progressive
PGR
$125B
$2.98M 0.75%
49,380
+4,510
+10% +$300K
IJH icon
43
iShares Core S&P Mid-Cap ETF
IJH
$123B
$2.97M 0.75%
89,380
+8,705
+11% +$318K
MNST icon
44
Monster Beverage
MNST
$93.2B
$2.91M 0.73%
118,222
-23,984
-17% -$651K
BIIB icon
45
Biogen
BIIB
$29.5B
$2.88M 0.73%
9,569
-787
-8% -$251K
DIS icon
46
Walt Disney
DIS
$168B
$2.83M 0.71%
25,766
+924
+4% +$105K
INTU icon
47
Intuit
INTU
$83.1B
$2.82M 0.71%
+14,339
New +$2.98M
BAC icon
48
Bank of America
BAC
$436B
$2.79M 0.7%
113,063
-2,132
-2% -$57.8K
MAR icon
49
Marriott International
MAR
$101B
$2.6M 0.66%
23,946
-2,032
-8% -$233K
OXY icon
50
Occidental Petroleum
OXY
$54.6B
$2.57M 0.65%
41,932
-1,452
-3% -$102K

Similar funds

Central Bank & Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Central Bank & Trust held 283 positions worth $396M, down 8.3% from $432M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Central Bank & Trust deployed $28.1M of net new capital in Q4 2018, opening 19 new positions and adding to 49 existing holdings. Its largest new stake was HP: 205,144 shares worth $4.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Lam Research, an estimated $4.47M trimmed.

  • Central Bank & Trust's largest Q4 2018 buy was HP: 205,144 shares worth $4.2M.
  • Central Bank & Trust added most to Vanguard Emerging Markets Government Bond ETF in Q4 2018, an estimated $16.3M increase.
  • Central Bank & Trust's biggest Q4 2018 reduction was Lam Research, cutting an estimated $4.47M.
  • Central Bank & Trust fully exited Aetna Inc in Q4 2018, selling an estimated $2.43M.
  • Central Bank & Trust's ten largest holdings make up 35% of its $396M portfolio in Q4 2018.
  • Central Bank & Trust opened 19 new positions and closed 16 in Q4 2018.
  • Central Bank & Trust's portfolio value fell 8.3% quarter-over-quarter to $396M.

Based on Central Bank & Trust's 13F filing for Q4 2018, filed 17 Jan 2019.